Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -22.36 Million USD | 8.71% |
| 2022 | -24.5 Million USD | -71.4% |
| 2021 | -14.29 Million USD | -5.69% |
| 2020 | -13.52 Million USD | -102.61% |
| 2019 | -6.67 Million USD | 46.53% |
| 2018 | -12.48 Million USD | -58.62% |
| 2017 | -7.87 Million USD | -56.08% |
| 2016 | -5.04 Million USD | -8.62% |
| 2015 | -4.64 Million USD | -11.5% |
| 2014 | -4.16 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -13.98 Million USD | 37.47% |
| 2024 Q2 | -18.27 Million USD | -30.68% |
| 2023 Q3 | -19.65 Million USD | -2.51% |
| 2023 Q1 | -18.36 Million USD | 25.04% |
| 2023 Q2 | -19.17 Million USD | -4.4% |
| 2023 Q4 | -22.36 Million USD | -13.78% |
| 2023 FY | -22.36 Million USD | 8.71% |
| 2022 Q3 | -36.51 Million USD | -12.07% |
| 2022 FY | -24.5 Million USD | -71.4% |
| 2022 Q1 | -31.67 Million USD | -121.58% |
| 2022 Q4 | -24.5 Million USD | 32.9% |
| 2022 Q2 | -32.58 Million USD | -2.87% |
| 2021 Q4 | -14.29 Million USD | 10.92% |
| 2021 Q3 | -16.04 Million USD | -13.97% |
| 2021 FY | -14.29 Million USD | -5.69% |
| 2021 Q2 | -14.07 Million USD | -13.56% |
| 2021 Q1 | -12.39 Million USD | 8.33% |
| 2020 Q3 | -13.91 Million USD | 13.7% |
| 2020 Q2 | -16.12 Million USD | -49.98% |
| 2020 Q4 | -13.52 Million USD | 2.81% |
| 2020 FY | -13.52 Million USD | -102.61% |
| 2020 Q1 | -10.75 Million USD | -61.06% |
| 2019 Q3 | -5.38 Million USD | 45.33% |
| 2019 Q4 | -6.67 Million USD | -23.9% |
| 2019 Q1 | -5.5 Million USD | 55.94% |
| 2019 Q2 | -9.85 Million USD | -79.17% |
| 2019 FY | -6.67 Million USD | 46.53% |
| 2018 Q3 | -17.12 Million USD | -350.9% |
| 2018 Q2 | -3.79 Million USD | 28.37% |
| 2018 FY | -12.48 Million USD | -58.62% |
| 2018 Q1 | -5.3 Million USD | 32.65% |
| 2018 Q4 | -12.48 Million USD | 27.08% |
| 2017 Q2 | -2.77 Million USD | -69.19% |
| 2017 Q4 | -7.87 Million USD | -50.99% |
| 2017 Q1 | -1.64 Million USD | 67.45% |
| 2017 FY | -7.87 Million USD | -56.08% |
| 2017 Q3 | -5.21 Million USD | -87.71% |
| 2016 FY | -5.04 Million USD | -8.62% |
| 2016 Q3 | -4.6 Million USD | 70.76% |
| 2016 Q2 | -15.75 Million USD | -299.22% |
| 2016 Q1 | -3.94 Million USD | 14.99% |
| 2016 Q4 | -5.04 Million USD | -9.44% |
| 2015 FY | -4.64 Million USD | -11.5% |
| 2015 Q4 | -4.64 Million USD | 0.0% |
| 2014 FY | -4.16 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 182.583% |
| BrainsWay Ltd. | -10.32 Million USD | -116.715% |
| Cerus Corporation | 84.35 Million USD | 126.514% |
| Envoy Medical, Inc. | -3.81 Million USD | -486.392% |
| electroCore, Inc. | -9.95 Million USD | -124.661% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -336.39% |
| IceCure Medical Ltd | -9.93 Million USD | -125.136% |
| Inogen, Inc. | -103.56 Million USD | 78.406% |
| OrthoPediatrics Corp. | -9.26 Million USD | -141.34% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -514.254% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -70.764% |
| MaxCyte, Inc. | -27.76 Million USD | 19.443% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -335.278% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -3784.384% |
| Orthofix Medical Inc. | 96.44 Million USD | 123.19% |
| PAVmed Inc | 29.08 Million USD | 176.893% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -32.033% |
| RxSight, Inc. | -6.68 Million USD | -234.805% |
| Sight Sciences, Inc. | -102.71 Million USD | 78.226% |
| SI-BONE, Inc. | 5.72 Million USD | 490.928% |
| TELA Bio, Inc. | -3.94 Million USD | -466.346% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 139.017% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 6453.693% |
| Acutus Medical, Inc. | 12.27 Million USD | 282.14% |
| Talis Biomedical Corporation | -57.06 Million USD | 60.807% |
| Spectral AI, Inc. | -3.5 Million USD | -538.817% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 53.432% |
| CVRx, Inc. | -59.95 Million USD | 62.698% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 1227.186% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1850.497% |
| Bioventus Inc. | 372.51 Million USD | 106.004% |
| Venus Concept Inc. | 74.3 Million USD | 130.101% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -119.652% |
| LivaNova PLC | 62.53 Million USD | 135.766% |
| 908 Devices Inc. | -115.09 Million USD | 80.568% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 106.974% |
| Nemaura Medical Inc. | 9.92 Million USD | 325.34% |
| NeuroPace, Inc. | 54.33 Million USD | 141.16% |
| LENSAR, Inc. | -18.31 Million USD | -22.133% |
| Apyx Medical Corporation | -5.15 Million USD | -334.188% |
| Cutera, Inc. | 288.3 Million USD | 107.758% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 397.605% |
| BioSig Technologies, Inc. | 262 Thousand USD | 8636.26% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 48.973% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -143.124% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 101.591% |
| Axonics, Inc. | -77.19 Million USD | 71.028% |
| Outset Medical, Inc. | 67.67 Million USD | 133.046% |
| IRIDEX Corporation | -4.28 Million USD | -421.572% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 87.437% |
| IRadimed Corporation | -47.71 Million USD | 53.132% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -639.095% |
| INVO Bioscience, Inc. | 8.45 Million USD | 364.639% |
| Telesis Bio, Inc. | 32.63 Million USD | 168.531% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -793.838% |
| Varex Imaging Corporation | 316.9 Million USD | 107.057% |
| Quipt Home Medical Corp. | 81.73 Million USD | 127.363% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -703.918% |
| Pulmonx Corporation | -42.36 Million USD | 47.203% |
| Dynatronics Corporation | 6.2 Million USD | 460.491% |
| Modular Medical, Inc. | -8.04 Million USD | -178.102% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -420.479% |
| Semler Scientific, Inc. | -57.13 Million USD | 60.852% |
| InMode Ltd. | -135.39 Million USD | 83.482% |
| Bruker Corporation | 891.3 Million USD | 102.509% |
| Cytosorbents Corporation | 4.18 Million USD | 634.79% |
| DexCom, Inc. | 2.02 Billion USD | 101.103% |
| Align Technology, Inc. | -840.47 Million USD | 97.339% |
| Viveve Medical, Inc. | -13.81 Million USD | -61.913% |
| ZimVie Inc. | 450.41 Million USD | 104.965% |
| Movano Inc. | -5.86 Million USD | -281.265% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 83.366% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -3784.384% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 1227.186% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 106.268% |
| Profound Medical Corp. | -18.17 Million USD | -23.03% |
| Insulet Corporation | 798.1 Million USD | 102.802% |
| enVVeno Medical Corporation | -2.21 Million USD | -908.341% |
| Surmodics, Inc. | -12.01 Million USD | -86.158% |
| iCAD, Inc. | -21.2 Million USD | -5.451% |
| Nuwellis, Inc. | -2.81 Million USD | -693.366% |
| Biotricity, Inc. | 23.09 Million USD | 196.849% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 123.881% |
| Aethlon Medical, Inc. | -4.5 Million USD | -396.817% |
| InspireMD, Inc. | -8.04 Million USD | -177.999% |
| PAVmed Inc. | 29.08 Million USD | 176.893% |
| BIOLASE, Inc. | 11.34 Million USD | 297.153% |
| Beyond Air, Inc. | 6.22 Million USD | 459.046% |
| FONAR Corporation | -14.66 Million USD | -52.503% |
| AxoGen, Inc. | 32.26 Million USD | 169.314% |
| Vivani Medical, Inc. | 42 Thousand USD | 53350.0% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -109.842% |
| Inari Medical, Inc. | -7.16 Million USD | -212.317% |
| UFP Technologies, Inc. | 40.77 Million USD | 154.851% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 828.828% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -368.739% |
| Tenon Medical, Inc. | -1.25 Million USD | -1682.072% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -194.044% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -87.527% |
| AdaptHealth Corp. | 2.21 Billion USD | 101.009% |
| Sintx Technologies, Inc. | 905 Thousand USD | 2571.271% |
| NanoVibronix, Inc. | -3.27 Million USD | -582.276% |
| Quanterix Corporation | -132.95 Million USD | 83.179% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -703.918% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 102.967% |
| TransMedics Group, Inc. | 121.13 Million USD | 118.463% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 14.572% |
| NeuroMetrix, Inc. | -1.49 Million USD | -1399.93% |
| Hyperfine, Inc. | -75.61 Million USD | 70.424% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 114.696% |
| Biomerica, Inc. | -3.38 Million USD | -560.709% |
| Bone Biologics Corporation | -3.02 Million USD | -638.956% |
| AVITA Medical, Inc. | -26.23 Million USD | 14.74% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -1116.54% |
| Silk Road Medical, Inc | 64.42 Million USD | 134.716% |